- May 21, 2019
- Category: What's New
Under the European Metrology Programme for Innovation and Research (EMPIR), DOSIsoft participated in the joint research project (JRP) on Metrology for clinical implementation of dosimetry in molecular radiotherapy (MRTDosimetry) since June 2016. Sébastien Vauclin was present at the final project meeting in Thessaloniki (Greece) on May 8th & 9th and did a speech on “DOSIsoft Dosimetry System” during the 4th scientific workshop for stakeholders on May 21st in the UK.
About the project
Metrology for clinical implementation of dosimetry in molecular radiotherapy (MRTDosimetry) is a joint research project (JRP) within the European Metrology Programme for Innovation and Research (EMPIR). It brings together expertise in metrology and nuclear medicine research in order to address the problem of determining the radiation dose to individual patients who are undergoing molecular radiotherapy (MRT), also known as ‘targeted radionuclide therapy’, or ‘nuclear medicine therapy’. The project began on 1 June 2016 and will run for three years, finishing on 31 May 2019.
The overall aim of the project is to provide the metrology for the clinical implementation of absorbed dose calculations in MRT. The project builds on the results and outputs from the preceding EMRP JRP HLT11 MetroMRT project, which took the first steps towards providing data, methods, protocols and guidance for MRT dosimetry in collaboration with many European MRT clinics as well as radiopharmaceutical companies and camera manufacturers. The focus of this follow-on project is “clinical implementation” and it is strongly directed by the involvement of leading MRT clinics across Europe as well as building on metrology expertise.